141 related articles for article (PubMed ID: 23290632)
21. Condom use and partnership intimacy among drug injectors and their sexual partners in Estonia.
Uusküla A; Abel-Ollo K; Markina A; McNutt LA; Heimer R
Sex Transm Infect; 2012 Feb; 88(1):58-62. PubMed ID: 22056984
[TBL] [Abstract][Full Text] [Related]
22. Developing an adherence support intervention for patients on antiretroviral therapy in the context of the recent IDU-driven HIV/AIDS epidemic in Estonia.
Laisaar KT; Uusküla A; Sharma A; DeHovitz JA; Amico KR
AIDS Care; 2013; 25(7):863-73. PubMed ID: 23391132
[TBL] [Abstract][Full Text] [Related]
23. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment.
Platt L; Bobrova N; Rhodes T; Uusküla A; Parry JV; Rüütel K; Talu A; Abel K; Rajaleid K; Judd A
AIDS; 2006 Oct; 20(16):2120-3. PubMed ID: 17053361
[TBL] [Abstract][Full Text] [Related]
24. Young and recent-onset injecting drug users are at higher risk for HIV.
Fennema JS; Van Ameijden EJ; Van Den Hoek A; Coutinho RA
Addiction; 1997 Nov; 92(11):1457-65. PubMed ID: 9519489
[TBL] [Abstract][Full Text] [Related]
25. Estimation of Intravenous Drug Users' Population in Kermanshah City, West of Iran in 2016 using Capture-recapture Method.
Azhdar F; Esmaeilnasab N; Moradi G; Roshani D; Ghaderi E; Nori B
J Res Health Sci; 2017 Aug; 17(3):e00388. PubMed ID: 28878110
[TBL] [Abstract][Full Text] [Related]
26. Estimating the population prevalence of injection drug use and infection with human immunodeficiency virus among injection drug users in Glasgow, Scotland.
Frischer M; Leyland A; Cormack R; Goldberg DJ; Bloor M; Green ST; Taylor A; Covell R; McKeganey N; Platt S
Am J Epidemiol; 1993 Aug; 138(3):170-81. PubMed ID: 8356960
[TBL] [Abstract][Full Text] [Related]
27. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection.
Panda S; Saha U; Pahari S; Nathan M; Poddar S; Neogi D; Sarkar M; Pal NK; Mahalanabis D
Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324
[TBL] [Abstract][Full Text] [Related]
28. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
[TBL] [Abstract][Full Text] [Related]
30. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
31. Estimating the number of people who inject drugs: a proposal to provide figures nationwide and its application to France.
Janssen E
J Public Health (Oxf); 2018 Jun; 40(2):e180-e188. PubMed ID: 28541440
[TBL] [Abstract][Full Text] [Related]
32. Was the 1988 HIV epidemic among Bangkok's injecting drug users a common source outbreak?
Wright NH; Vanichseni S; Akarasewi P; Wasi C; Choopanya K
AIDS; 1994 Apr; 8(4):529-32. PubMed ID: 8011258
[TBL] [Abstract][Full Text] [Related]
33. Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia.
Uusküla A; Raag M; Vorobjov S; Rüütel K; Lyubimova A; Levina OS; Heimer R
BMC Public Health; 2015 Dec; 15():1255. PubMed ID: 26684815
[TBL] [Abstract][Full Text] [Related]
34. Study of human rights violations faced by women who use drugs in Estonia.
Kontautaite A; Matyushina-Ocheret D; Plotko M; Golichenko M; Kalvet M; Antonova L
Harm Reduct J; 2018 Nov; 15(1):54. PubMed ID: 30400951
[TBL] [Abstract][Full Text] [Related]
35. Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.
Vorobjov S; Uusküla A; Abel-Ollo K; Talu A; Jarlais DD
J Urban Health; 2009 Nov; 86(6):918-28. PubMed ID: 19921542
[TBL] [Abstract][Full Text] [Related]
36. Mark-recapture estimates of injecting drug users in Sydney.
Duque-Portugal F; Martin AJ; Taylor R; Ross MW
Aust J Public Health; 1994 Jun; 18(2):201-4. PubMed ID: 7948339
[TBL] [Abstract][Full Text] [Related]
37. Changes in the prevalence of injection drug use among adolescents and young adults in large U.S. metropolitan areas.
Chatterjee S; Tempalski B; Pouget ER; Cooper HL; Cleland CM; Friedman SR
AIDS Behav; 2011 Oct; 15(7):1570-8. PubMed ID: 21739288
[TBL] [Abstract][Full Text] [Related]
38. Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent-driven sampling in Estonia.
Uusküla A; Johnston LG; Raag M; Trummal A; Talu A; Des Jarlais DC
J Urban Health; 2010 Mar; 87(2):304-317. PubMed ID: 20131018
[TBL] [Abstract][Full Text] [Related]
39. The trends and risk factors for hepatitis B occurrence in Estonia.
Paat G; Uusküla A; Tefanova V; Tallo T; Priimägi L; Ahi K
Cent Eur J Public Health; 2009 Jun; 17(2):108-11. PubMed ID: 19662830
[TBL] [Abstract][Full Text] [Related]
40. A surveillance report of HIV status and high risk behaviors among rapid testing participants in Tallinn, Estonia.
Parker RD; Rüütel K
AIDS Behav; 2011 May; 15(4):761-6. PubMed ID: 20703793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]